Yahoo Web Search

Search results

  1. Mario Natalino Concetto Amendola (8 December 1910 – 22 December 1993) was an Italian screenwriter, film director and dramatist. Biography [ edit ] Amendola was born in Recco , which is located in Genova to parents from Rome.

  2. Mario Amendola. Writer: Trappola per sette spie. Mario Amendola was born on 8 December 1910 in Recco, Liguria, Italy. He was a writer and director, known for Trappola per sette spie (1966), Sword of Damascus (1964) and Who Finds a Friend Finds a Treasure (1981).

    • Writer, Director, Actor
    • December 8, 1910
    • Mario Amendola
    • December 22, 1993
  3. Dec 2016-pres July 2015-pres May 2010-Jan 2015 Sep 2007-May 2010 Aug 2005-Nov 2005 Jan 2003-Sep 2007. Mario AMENDOLA. CULUM VITAERESEARCH EXPERIENCEChargé de Recherche de 1ère classe (. R1) INSERM, UMR_S951, Evry, FR. Team Leader of the ‘Therapeutic genome editi. g’ group, UMR_S951, Evry, FR. Postdoctoral fellow, The Netherlands C.

  4. The research in my laboratory focuses on the development of new gene therapy approaches…. · Expérience : INSERM · Formation : Université d'Evry-Val d'Essonne · Lieu : Paris et périphérie · 500 relations ou plus sur LinkedIn. Consultez le profil de Mario Amendola sur LinkedIn, une communauté professionnelle d’un milliard de membres.

    • 1.3K
    • INSERM
  5. Mario AMENDOLA, PhD 1 CURRICULUM VITAE (updated 2023) PERSONAL DATA Name: Mario Amendola Nationality: Italian E-mail: mamendola@genethon.fr WORKING EXPERIENCE Nov 2022-pres Associate Professor of Molecular Biology, University of Foggia, Italy Dec 2016-pres Chargé de Recherche de 1ère classe (CR1) INSERM, UMR_S951, Evry, FR.

  6. Mar 2015. Mario Amendola. Bas van Steensel. In mammals, the nuclear lamina interacts with hundreds of large genomic regions, termed lamina-associated domains (LADs) that are generally in a ...

  7. People also ask

  8. www.genethon.com › our-science › our-research-teamsGene Editing - Généthon

    The team is mainly focused on the development of efficient and safe gene editing techniques to treat rare genetic diseases in vivo and ex vivo. The team’s researchers Mario Amendola, PhD Team leaderInserm Researcher Expertise: gene therapy, gene editing, viral vectors, expression of hematopoietic stem cells 0000-0002-1188-8856 Guillaume Corre,PhD Research engineer, bioinformatician Expertise ...